期刊文献+

小剂量沙利度胺联合治疗骨髓增生异常综合征疗效观察 被引量:4

原文传递
导出
摘要 目的评价小剂量沙利度胺联合治疗MDS的疗效。方法低中危病例15例,低危组给予小剂量沙利度胺加司坦唑醇、促红细胞生成素,中危组给予小剂量沙利度胺加全反式维甲酸、小剂量阿糖胞苷化疗,3个月后评价疗效。结果低危组有效率达77.8%。中危组有效率33.3%。在改善贫血方面,对低危的MDS红系效果改善明显,对巨核系效果不佳。结论联合小剂量沙利度胺治疗MDS对改善贫血效果显著。
出处 《中国误诊学杂志》 CAS 2012年第3期525-525,共1页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献3

  • 1肖志坚,郝玉书.骨髓增生异常综合征的诊断分型与预后判断及疗效标准[J].中华内科杂志,2002,41(12):846-848. 被引量:49
  • 2Sa AW, Olga P, Jeffrey LJ, et al. Detection 0f paroxysmal nocturh- al hemoglobinuria clones in patients with myelodysplastie syn- dromes and related bone marrow diseases, with emphasis on diag- nostic pitfalls and caveats[J].Haematologica, 2009,94 (1) : 29-37.
  • 3Moreno-Aspitia A, Geyer S, Li CY, et al. N998B: multicenter phase II trial of thalidomide in adult patients with myelodysplas- tie syndromes[J]. Blood, 2007,100 : 96a.

二级参考文献5

  • 1Cheson BD,Bennett JM,Kantarjian H,et al.Report of an international working group to standardize response criteria for myelodysplastic syndromes[].Blood.2000
  • 2N sslinger T,Reisner R,Koller E,et al.Myelodysplastic syndromes,from French-Americam-British to World Health Organization: comprison of classification on 431 unselected patients from a single institute[].Blood.2001
  • 3Bennett JM.World Health Organization classification of the acute leukemias and myelodysplastic syndrome[].International Journal of Hematology.2000
  • 4Harris NL,Jaffe ES,Diebold T,et al.World Health Orgnization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie House,Virginia, November 1997[].Journal of Clinical Oncology.1999
  • 5Greenberg P,Cox C,LeBeau MM,et al.International scoring system for evaluating prognosis in myelodysplastic syndromes[].Blood.1997

共引文献48

同被引文献26

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部